Quantcast

Latest Radiofrequency ablation Stories

2010-12-07 07:00:00

SAN RAMON, Calif., Dec. 7, 2010 /PRNewswire/ -- Estech announced today that it has completed $8.5 million in equity financing to pursue further development of its minimally invasive cardiac ablation surgical platform. Investors participating in the financing include Saints Capital Everest, Telegraph Hill Partners, NBGI Ventures and Tullis Health Investors. Over the last two years, Estech has raised over $28 million in equity financing to fund its innovation and business development...

2010-11-22 04:55:00

WATERLOO, Belgium, November 22, 2010 /PRNewswire/ -- According to data published last week in Circulation Cardiovascular Quality and Outcomes, patients with a common heart rhythm disorder, called atrial fibrillation, who were treated with catheter ablation using the NaviStar(R)ThermoCool(R) Catheter, reported markedly fewer symptoms and substantially improved quality of life than patients treated with antiarrhythmia drugs at one year. Atrial fibrillation, or AFib as it is more...

2010-11-16 07:07:00

TORONTO, Nov. 16, 2010 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the use of cryoablation as a treatment for cancers of the lung and kidney will take off at the expense of radiofrequency ablation in the US over the next five years. The US cryoablation device market, consisting of disposable cryoablation devices used in the treatment of kidney, liver, and lung cancer, was valued at approximately $30...

2010-11-10 07:30:00

MORRISVILLE, N.C., Nov. 10, 2010 /PRNewswire/ -- nContact Surgical, Inc. (nContact), a cardiac ablation device manufacturer, announced today that it has closed a $16 million Series D round of equity financing, bringing the company's total financing since inception to $42.4 million. The financing was led by existing investors, Harbert Venture Partners, and included new investors, ZMV Associates. The company expects this financing to support its three ongoing clinical trials, further product...

2010-10-14 15:17:00

Physicians at Mayo Clinic's Florida campus are among the first in the nation to use a technique known as MRI-guided laser ablation to heat up and destroy kidney and liver tumors. So far, five patients have been successfully treated "” meaning no visible tumors remained after the procedure. They join their colleagues at Mayo Clinic's site in Rochester, Minn., who were the first to use laser ablation on patients with recurrent prostate tumors. Although the treatment techniques are in the...

2010-10-04 06:30:00

COLUMBIA, Md., Oct. 4 /PRNewswire/ -- Celsion Corporation (Nasdaq: CLSN), a leading oncology drug development company, announced that the Company has reached agreement with the U.S. Food and Drug Administration (FDA) that the requirements for non-clinical studies have been met for the New Drug Application (NDA) of ThermoDox. The FDA has provided written guidance that the Company is not required to conduct any additional non-clinical pharmacology, safety pharmacology and general...

2010-09-21 06:29:00

DALLAS, September 21, 2010 /PRNewswire/ -- ReportsandReports announces it will carry U.S. Market for Cardiac Rhythm Management, Electrophysiology and Ablation Devices 2010 Research Report in its store. Browse the complete Report on: http://www.reportsandreports.com/reports/34141-us-market-for-cardiac-rhythm-m anagement-electrophysiology-and-.html Search More Then 50000 Market Research Reports at ReportsandReports (http://www.reportsandreports.com/) Browse All IData Research...

6957920d9d1618f03b229bee335b96e41
2010-09-15 09:25:00

Atrial fibrillation is a heart disorder that affects more than two million Americans, and is considered a key contributor to blood clots and stroke. Now researchers from North Carolina State University are developing a new computerized catheter that could make the surgical treatment of atrial fibrillation faster, cheaper and more effective "“ while significantly decreasing radiation exposure related to the treatment. "We are developing a robotic catheter with significantly improved...

2010-09-08 09:23:00

ST. LOUIS, Sept. 8 /PRNewswire-FirstCall/ -- Stereotaxis, Inc. (Nasdaq: STXS) highlighted significant new additions to the body of evidence demonstrating exceptional clinical outcomes achieved with its Niobe® Magnetic Navigation System in ventricular tachycardia (VT) ablation. At the European Cardiology Society Annual Congress in Stockholm last week, the research team led by Dr. Tamas Szili-Torok from the Erasmus Medical Center in Rotterdam presented the first...

2010-09-07 07:00:00

SUNNYVALE, Calif., Sept. 7 /PRNewswire/ -- BARRX Medical, Inc., a world leader in endoscopic treatment solutions for treating precancerous lesions of the esophagus as well as other chronic gastrointestinal diseases, announced today that the company has signed an exclusive agreement with Medico's Hirata for distribution of the HALO Radiofrequency Ablation System in Japan. Japan has one of the highest concentrations of esophageal squamous cell cancers in the world. Traditionally treated by...


Word of the Day
baudekin
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.
Related